Josh Kaufman

Partner

My clients turn to me as a trusted advisor in critical financing and corporate transactions.

josh.kaufman@cooley.com

Josh Kaufman's practice focuses on capital markets transactions, primarily in the life sciences and technology verticals. He represents US and foreign private issuers and underwriters in a wide variety of public offerings and private placements. Josh has advised clients on more than 200 financing transactions with an aggregate value in excess of $100 billion. He also counsels clients with respect to public company and corporate governance matters; general corporate and commercial matters; mergers & acquisitions and other strategic transactions; and dealings with securityholders, securities exchanges and regulatory bodies.

Download full bio 

Experience

  • IN8bio – $40 Million IPO 

  • Sprinklr – $293 Million IPO 

  • Centessa Pharmaceuticals – $380 Million IPO 

  • Smart Share Global – $150 Million IPO  

  • LAVA Therapeutics – $107 Million IPO 

  • View all

Education

  • Columbia University School of Law
    JD, 2002

  • Columbia University Graduate School of Business
    MBA, 2002

  • Harvard University
    AB, 1998


Admissions & Credentials

New York